Malcolm Maclure

Summary

Country: Canada

Publications

  1. doi Case-crossover designs compared with dynamic follow-up designs
    Malcolm Maclure
    Pharmaceutical Services Division, British Columbia Ministry of Health, Victoria, BC, Canada
    Epidemiology 19:176-8. 2008
  2. ncbi Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations
    Malcolm Maclure
    School of Health Information Science, University of Victoria, Victoria, British Columbia, Canada
    Med Care 45:S44-9. 2007
  3. ncbi 'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies
    Malcolm Maclure
    School of Health Information Science, University of Victoria, Victoria, British Columbia, Canada
    Pharmacoepidemiol Drug Saf 16:850-3. 2007
  4. ncbi Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners
    Malcolm Maclure
    School of Health Information Science, Faculty of Human and Social Development, University of Victoria, British Columbia BC, Canada
    Basic Clin Pharmacol Toxicol 98:243-52. 2006
  5. doi When should case-only designs be used for safety monitoring of medical products?
    Malcolm Maclure
    Department Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Pharmacoepidemiol Drug Saf 21:50-61. 2012
  6. pmc Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues
    Malcolm Maclure
    School of Health Information Science, University of Victoria, B C V8W 3P5, Canada
    Milbank Q 83:131-47. 2005
  7. doi Camouflaged sampling and contacting of people from administrative databases: reaching target patients without knowing who they are
    Malcolm Maclure
    School of Health Information Science, Faculty of Human and Social Development, University of Victoria, Victoria, BC, Canada
    Pharmacoepidemiol Drug Saf 17:790-7. 2008
  8. ncbi Information system support as a critical success factor for chronic disease management: Necessary but not sufficient
    Carolyn J Green
    School of Health Information Science, University of Victoria, Victoria, BC, Canada
    Int J Med Inform 75:818-28. 2006
  9. pmc Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children
    Richard L Morrow
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Victoria, BC
    CMAJ 184:755-62. 2012
  10. ncbi Using administrative healthcare data to recruit study subjects: experience with 'camouflaged sampling'
    Larry D Lynd
    Department of Health Care and Epidemiology, Faculty of Medicine University of British Columbia, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada
    Eur J Epidemiol 19:517-25. 2004

Detail Information

Publications39

  1. doi Case-crossover designs compared with dynamic follow-up designs
    Malcolm Maclure
    Pharmaceutical Services Division, British Columbia Ministry of Health, Victoria, BC, Canada
    Epidemiology 19:176-8. 2008
  2. ncbi Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations
    Malcolm Maclure
    School of Health Information Science, University of Victoria, Victoria, British Columbia, Canada
    Med Care 45:S44-9. 2007
    ..Centralized administrative databases enable low-cost pragmatic randomized trials (PRTs) of drug effectiveness and safety. We simplified the PRT strategy by using designed delays (DD) to evaluate drug policies...
  3. ncbi 'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies
    Malcolm Maclure
    School of Health Information Science, University of Victoria, Victoria, British Columbia, Canada
    Pharmacoepidemiol Drug Saf 16:850-3. 2007
  4. ncbi Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners
    Malcolm Maclure
    School of Health Information Science, Faculty of Human and Social Development, University of Victoria, British Columbia BC, Canada
    Basic Clin Pharmacol Toxicol 98:243-52. 2006
    ..A decade of progress on methods for evaluating prescribing improvement programs with drug claims data has enabled planning of routine randomized pragmatic trials of education and policies in primary care in Canada...
  5. doi When should case-only designs be used for safety monitoring of medical products?
    Malcolm Maclure
    Department Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
    Pharmacoepidemiol Drug Saf 21:50-61. 2012
    ..To assess case-only designs for surveillance with administrative databases...
  6. pmc Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues
    Malcolm Maclure
    School of Health Information Science, University of Victoria, B C V8W 3P5, Canada
    Milbank Q 83:131-47. 2005
  7. doi Camouflaged sampling and contacting of people from administrative databases: reaching target patients without knowing who they are
    Malcolm Maclure
    School of Health Information Science, Faculty of Human and Social Development, University of Victoria, Victoria, BC, Canada
    Pharmacoepidemiol Drug Saf 17:790-7. 2008
    ..Methods are needed for using confidential data to select and reach patients without compromising their health privacy...
  8. ncbi Information system support as a critical success factor for chronic disease management: Necessary but not sufficient
    Carolyn J Green
    School of Health Information Science, University of Victoria, Victoria, BC, Canada
    Int J Med Inform 75:818-28. 2006
    ..Improvement of chronic disease management in primary care entails monitoring indicators of quality over time and across patients and practices. Informatics tools are needed, yet implementing them remains challenging...
  9. pmc Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children
    Richard L Morrow
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Victoria, BC
    CMAJ 184:755-62. 2012
    ..We sought to determine the influence of relative age within a grade on the diagnosis and pharmacologic treatment of attention-deficit/hyperactivity disorder (ADHD) in children...
  10. ncbi Using administrative healthcare data to recruit study subjects: experience with 'camouflaged sampling'
    Larry D Lynd
    Department of Health Care and Epidemiology, Faculty of Medicine University of British Columbia, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada
    Eur J Epidemiol 19:517-25. 2004
    ..To recruit a sample of asthmatics heterogeneous for short-acting (SA) beta-agonist use while protecting their privacy, and to compare participants recruited via 'camouflaged sampling' to those recruited through media advertising...
  11. ncbi Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02120, USA
    Clin Pharmacol Ther 74:388-400. 2003
    ....
  12. ncbi Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma
    Colin R Dormuth
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin Ther 28:964-78; discussion 962-3. 2006
    ..Evaluations of drug cost-sharing policies within the same population are needed for a fair comparison of different options...
  13. ncbi Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Circulation 115:2128-35. 2007
    ....
  14. ncbi The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada
    Deborah A Marshall
    Centre for Evaluation of Medicines, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
    Health Policy 84:1-13. 2007
    ..Ontario required physicians to submit the clinical indications for their use on the prescription. British Columbia required physicians to seek and receive prior authorisation from the drug plan...
  15. ncbi Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance
    Sebastian Schneeweiss
    Divison of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Ave BLI 341, Boston, MA 02115, USA
    J Clin Epidemiol 55:833-41. 2002
    ..Results from nonrandomized comparisons of subgroups defined by their compliance to a policy change should generally be interpreted cautiously, and several biases should be explored...
  16. pmc Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization
    Sebastian Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA
    CMAJ 166:737-45. 2002
    ..The objective of this study was to analyze the effect of reference-based pricing of angiotensin-converting enzyme (ACE) inhibitors on drug utilization, cost savings and potential substitution with other medication classes...
  17. pmc Does knowledge of medication prices predict physicians' support for cost effective prescribing policies
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Can J Clin Pharmacol 15:e286-94. 2008
    ..Years after implementation, these policies remain controversial among physicians...
  18. ncbi Prescription duration after drug copay changes in older people: methodological aspects
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115, USA
    J Am Geriatr Soc 50:521-5. 2002
    ..Reference pricing, a copayment for expensive medications above a fixed limit, for angiotensin-converting enzyme(ACE) inhibitors in older British Columbia residents, is used as a case example...
  19. ncbi A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Clin Pharmacol Ther 79:379-88. 2006
    ..We evaluated the clinical and economic consequences of coverage restriction for 3 leading proton pump inhibitors (PPIs) in a large-scale natural experiment...
  20. ncbi Commitment to change statements can predict actual change in practice
    Jacqueline Wakefield
    Education and Research Services, Foundation for Medical Practice Education, McMaster University, 1280 Main St West, DTC Basement, Hamilton, ON L8S 4L8
    J Contin Educ Health Prof 23:81-93. 2003
    ..As part of an educational randomized controlled trial, this study documented changes that family physicians committed to make in their prescribing and then used third-party data to examine actual changes...
  21. pmc Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations
    Sebastian Schneeweiss
    Brigham and Women s Hospital and Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics, 1620 Tremont St Suite 3030, Boston, MA 02120, USA
    BMJ 328:560. 2004
    ..To compare the results of a randomised and an observational evaluation of the same policy that restricted reimbursement for nebulised respiratory medications in adult patients in a community setting...
  22. pmc Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial
    Colin R Dormuth
    Therapeutics Initiative, University of British Columbia, Vancouver
    CMAJ 171:1057-61. 2004
    ..We sought to measure the impact of a series of evidence-based drug therapy letters mailed to physicians in British Columbia on prescribing to newly treated patients...
  23. pmc Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Gigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Gen Intern Med 19:444-50. 2004
    ..We sought to evaluate and rank the performance of comorbidity scores across selected U.S. and Canadian elderly populations using health care utilization databases...
  24. ncbi Better Prescribing Project: a randomized controlled trial of the impact of case-based educational modules and personal prescribing feedback on prescribing for hypertension in primary care
    Carol P Herbert
    University of Western Ontario, Faculty of Medicine and Dentistry, Health Sciences Addition, London, Ontario N6A 5C1, Canada
    Fam Pract 21:575-81. 2004
    ..The purpose of this study was to assess the impacts of individualized prescribing feedback and interactive small group education aimed at encouraging evidence-based prescribing in family/general practice...
  25. ncbi Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 42:653-60. 2004
    ..Critics argued that drug plan savings are offset by administrative costs and increased spending on other health services...
  26. ncbi Consultation with the general practitioner triggered by advice from social network members
    Tina Eriksson
    Research Unit of General Practice, University of Southern Denmark, Odense, Denmark
    Scand J Prim Health Care 22:54-9. 2004
    ..To investigate whether advice from a person's social network triggers contact with the general practitioner (GP)...
  27. pmc To what extent do mass media health messages trigger patients' contacts with their GPs?
    Tina Eriksson
    Department of General Practice, Centre of Health and Society, University of Copenhagen, Øster Farimagsgade 5, Postboks 2099, 1014 Copenhagen K, Denmark
    Br J Gen Pract 55:212-7. 2005
    ..A recent Cochrane review concluded that mass media intervention may play an important role in influencing the use of health services, but little is known about the effects of unplanned untargeted information in the media...
  28. ncbi Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial
    Jens Søndergaard
    Research Unit of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Odense University, Odense, Denmark
    Eur J Clin Pharmacol 58:127-32. 2002
    ..To evaluate the effects of postal feedback with clinically relevant data on general practitioners' prescribing compared with feedback with aggregate data on prescribing patterns of asthma drugs...
  29. pmc The impact of cost sharing on antidepressant use among older adults in British Columbia
    Philip S Wang
    National Institute of Mental Health, Bethesda, MD 20892 9629, USA
    Psychiatr Serv 59:377-83. 2008
    ....
  30. pmc Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications
    Colin R Dormuth
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Clin Ther 30:1038-50. 2008
    ..Objective: The aim of this study was to compare the effects of 2 recent cost-sharing policies on emergency hospitalizations due to chronic obstructive pulmonary disease, asthma, or emphysema (CAE), and on physician visits...
  31. ncbi Educational attainment and myocardial infarct-related congestive heart failure (the Determinants of Myocardial Infarction Onset Study)
    Kenneth J Mukamal
    Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, RO 114, Boston, MA 02215, USA
    Am J Cardiol 93:1288-91. 2004
    ..75; 95% confidence interval, 0.57 to 0.99; p for trend 0.02), with similar findings among men, women, whites, and blacks...
  32. pmc Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Med Care 45:S131-42. 2007
    ..The goal of restricting study populations is to make patients more homogeneous regarding potential confounding factors and treatment effects and thereby achieve less biased effect estimates...
  33. pmc Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St Ste 3030, Boston, MA 02120, USA
    Am J Manag Care 13:445-52. 2007
    ....
  34. pmc Pharmaceutical cost containment with reference-based pricing: time for refinements
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Mass 02115, USA
    CMAJ 167:1250-1. 2002
  35. ncbi Caffeinated coffee consumption and mortality after acute myocardial infarction
    Kenneth J Mukamal
    Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA
    Am Heart J 147:999-1004. 2004
    ..Previous studies have generally suggested no effect of coffee consumption on the risk of acute myocardial infarction. The effect of coffee consumption on prognosis after acute myocardial infarction is uncertain...
  36. ncbi Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia
    Margreet S Duetz
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Clin Ther 25:273-84. 2003
    ..Gender-specific attitudes and communication styles are known to influence both the content and outcome of medical visits. Therefore, gender-specific differences in response to cost containment may also occur...
  37. ncbi A population-based case-crossover and case-control study of alcohol and the risk of injury
    Daniel C Vinson
    Department of Family and Community Medicine, M231 Health Sciences, University of Missouri Columbia, Columbia, Missouri 65212, USA
    J Stud Alcohol 64:358-66. 2003
    ..This study investigated the relationship between alcohol and the risk of acute injury, examining both short-term (drinking over a few hours) and long-term exposures (past-month hazardous drinking and current alcohol use disorders)...
  38. ncbi Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate
    Murray A Mittleman
    Cardiovascular Epidemiology Research Unit, Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 96:443-6. 2005
    ....
  39. ncbi Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors
    Sebastian Schneeweiss
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    N Engl J Med 346:822-9. 2002
    ..Although reference pricing may reduce the costs of prescription drugs, there is concern that patients may switch to less effective medications or stop treatment...